(Q57675150)

11

0 references

author name string

Hiroshi Takayanagi

1

0 references

Sunhwa Kim

2

0 references

Hiroshi Suzuki

4

0 references

Tomohiko Suzuki

5

0 references

Kojiro Sato

6

0 references

Taeko Yokochi

7

0 references

Hiromi Oda

8

0 references

Kozo Nakamura

9

0 references

Nobutaka Ida

10

0 references

Tadatsugu Taniguchi

Therapeutic approaches to bone diseases

12

0 references

language of work or name

English

0 references

publication date

April 2002

0 references

published in

Nature

0 references

volume

416

0 references

issue

6882

0 references

page(s)

744-749

0 references

cites work

1 reference

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

7 January 2021

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

7 January 2021

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

7 January 2021

Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis

1 reference

7 January 2021

T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ

1 reference

7 January 2021

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

1 reference

7 January 2021

Genetic control of skeletal development

1 reference

7 January 2021

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling

1 reference

7 January 2021

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

1 reference

7 January 2021

Bone and haematopoietic defects in mice lacking c-fos

1 reference

7 January 2021

c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling

1 reference

7 January 2021

Cell biology of the osteoclast

1 reference

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

7 January 2021

Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains

1 reference

7 January 2021

IRF family of transcription factors as regulators of host defense

1 reference

7 January 2021

How cells respond to interferons

1 reference

7 January 2021

Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase

1 reference

7 January 2021

Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo

1 reference

7 January 2021

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

1 reference

7 January 2021

Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts

1 reference

7 January 2021

Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover

1 reference

7 January 2021

Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies

1 reference

7 January 2021

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

1 reference

7 January 2021

CD8( ) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling

1 reference

7 January 2021